Causes of Diminished Ovarian Function

Ovarian insufficiency—also known as diminished ovarian reserve (DOR) or primary ovarian insufficiency (POI) when occurring before age 40—refers to a decline in the quantity and quality of ovarian follicles, resulting in reduced estrogen production and impaired ovulation. The underlying causes are multifactorial and can be broadly categorized as genetic, iatrogenic, autoimmune, infectious, metabolic, or idiopathic.

Genetic factors play a prominent role: chromosomal abnormalities such as Turner syndrome (45,X), Fragile X premutation (FMR1 gene), and mutations in genes involved in DNA repair or folliculogenesis—including BMP15, FOXL2, and STAG3—can disrupt normal ovarian development or accelerate follicular depletion. Iatrogenic causes include prior chemotherapy (especially alkylating agents like cyclophosphamide), pelvic radiotherapy, and surgical oophorectomy or extensive ovarian tissue resection.

Autoimmune ovarian insufficiency arises when the immune system mistakenly targets ovarian antigens—such as steroidogenic enzymes (e.g., 17α-hydroxylase, side-chain cleavage enzyme) or germ cell proteins—leading to lymphocytic infiltration and follicular atresia. It is frequently associated with other autoimmune conditions, including Addison’s disease, thyroiditis, and type 1 diabetes mellitus.

Infectious etiologies are rare but documented; mumps oophoritis, though uncommon, may cause inflammatory damage to ovarian stroma and follicles. Metabolic contributors include severe malnutrition, prolonged hypothalamic amenorrhea (often linked to excessive exercise or eating disorders), and mitochondrial dysfunction affecting granulosa cell energetics.

In approximately 90% of cases of early-onset ovarian insufficiency, no definitive cause is identified—classified as idiopathic. Emerging research also points to environmental influences, including exposure to endocrine-disrupting chemicals (e.g., bisphenol A, phthalates), smoking, and advanced maternal age, which collectively contribute to oxidative stress and accelerated primordial follicle activation or apoptosis.